OBJECTIVE: Although the majority of women with ovarian carcinoma report symptoms prior to diagnosis, little is known about comparative symptom presentation by histological type, stage, grade, or ethnicity. METHODS: We conducted a population-based study including 622 women with invasive ovarian carcinoma diagnosed from 1993 to 2008. Epidemiological and symptom data were collected using an interviewer-administered questionnaire. Symptoms established as significant predictors of ovarian carcinoma were examined in relation to patient and tumor characteristics, using unconditional multivariate logistic regression and general linear models. RESULTS: Symptom presentation and duration differed significantly among women with ovarian carcinoma by stage, tumor histology, and grade, but not ethnicity. Significant differences were observed by histology in reporting a distended abdomen, abnormal vaginal bleeding, and bowel symptoms. Compared to women diagnosed with serous carcinoma, women with mucinous tumors were 2.6 times more likely to report a distended abdomen; women with endometrioid carcinoma were three times more likely to report abnormal bleeding. Women with serous tumors were significantly more likely to report bowel symptoms than were women diagnosed with other histological types. The majority of women with serous tumors were diagnosed with advanced cancer and had shorter duration of symptoms than women with early stage disease. In contrast, women with mucinous tumors were generally diagnosed at an early stage and had longer duration of symptoms (p=0.009) if diagnosed at an advanced stage. CONCLUSION: The study provides evidence that the early diagnosis of ovarian cancer is largely determined by tumor histological type.
OBJECTIVE: Although the majority of women with ovarian carcinoma report symptoms prior to diagnosis, little is known about comparative symptom presentation by histological type, stage, grade, or ethnicity. METHODS: We conducted a population-based study including 622 women with invasive ovarian carcinoma diagnosed from 1993 to 2008. Epidemiological and symptom data were collected using an interviewer-administered questionnaire. Symptoms established as significant predictors of ovarian carcinoma were examined in relation to patient and tumor characteristics, using unconditional multivariate logistic regression and general linear models. RESULTS: Symptom presentation and duration differed significantly among women with ovarian carcinoma by stage, tumor histology, and grade, but not ethnicity. Significant differences were observed by histology in reporting a distended abdomen, abnormal vaginal bleeding, and bowel symptoms. Compared to women diagnosed with serous carcinoma, women with mucinous tumors were 2.6 times more likely to report a distended abdomen; women with endometrioid carcinoma were three times more likely to report abnormal bleeding. Women with serous tumors were significantly more likely to report bowel symptoms than were women diagnosed with other histological types. The majority of women with serous tumors were diagnosed with advanced cancer and had shorter duration of symptoms than women with early stage disease. In contrast, women with mucinous tumors were generally diagnosed at an early stage and had longer duration of symptoms (p=0.009) if diagnosed at an advanced stage. CONCLUSION: The study provides evidence that the early diagnosis of ovarian cancer is largely determined by tumor histological type.
Authors: Marc T Goodman; Holly L Howe; Ko Hui Tung; Joellyn Hotes; Barry A Miller; Steven S Coughlin; Vivien W Chen Journal: Cancer Date: 2003-05-15 Impact factor: 6.860
Authors: Marc T Goodman; Catherine N Correa; Ko-Hui Tung; Steven D Roffers; Xiao Cheng Wu; John L Young; Lynne R Wilkens; Michael E Carney; Holly L Howe Journal: Cancer Date: 2003-05-15 Impact factor: 6.860
Authors: Robert F Ozols; Michael A Bookman; Denise C Connolly; Mary B Daly; Andrew K Godwin; Russell J Schilder; Xiangxi Xu; Thomas C Hamilton Journal: Cancer Cell Date: 2004-01 Impact factor: 31.743
Authors: Penelope M Webb; David M Purdie; Sonia Grover; Susan Jordan; Marie-Louise Dick; Adèle C Green Journal: Gynecol Oncol Date: 2004-01 Impact factor: 5.482
Authors: Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Marc T Goodman Journal: Gynecol Oncol Date: 2009-05-22 Impact factor: 5.482
Authors: Allison J Love; Pascal Lambert; Donna Turner; Robert Lotocki; Erin Dean; Shaundra Popowich; Alon D Altman; Mark W Nachtigal Journal: CMAJ Open Date: 2017-02-07
Authors: Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Marcela F Paes; Renata D Daltoé; Klesia P Madeira; Lucas Cd Rezende; Gabriela M Sirtoli; Alice L Herlinger; Leticia S Souza; Luciana B Coitinho; Débora Silva; Murilo F Cerri; Ana Cristina N Chiaradia; Alex A Carvalho; Ian V Silva; Leticia Ba Rangel Journal: J Ovarian Res Date: 2011-08-09 Impact factor: 4.234
Authors: R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery Journal: Br J Cancer Date: 2015-03-31 Impact factor: 7.640
Authors: Niek Hugen; Michiel Simons; Altuna Halilović; Rachel S van der Post; Anna J Bogers; Monica Aj Marijnissen-van Zanten; Johannes Hw de Wilt; Iris D Nagtegaal Journal: J Pathol Clin Res Date: 2014-11-05